Effect of taurine on oxidative stress and apoptosis-related protein expression in trinitrobenzene sulphonic acid-induced colitis

Clinical and Experimental Immunology

Volumn 152, Issue 1, 2008, Pages 102-110

  Giris M ^a   Depboylu, B ^a   Dogru Abbasoglu S ^a   Erbil, Y ^a   Olgac V ^b   Alis H ^a   Aykac Toker G ^a   Uysal, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Oxidative stress; Rat; Taurine; TNBS induced colitis

Indexed keywords

GLUTATHIONE; MALONALDEHYDE; MYELOPEROXIDASE; PROTEIN BAX; PROTEIN BCL 2; TAURINE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLON; DRUG EFFECT; DRUG INDUCED DISEASE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; INFLAMMATION; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ULCERATIVE COLITIS;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; COLITIS, ULCERATIVE; COLON; DISEASE MODELS, ANIMAL; GLUTATHIONE; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PEROXIDASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; TAURINE; TRINITROBENZENESULFONIC ACID;

EID: 40449112968     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03599.x     Document Type: Article

References (40)

1. Hendrickson BA, Gokhale R, Cho JH. Clinic aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002 15 : 79 94.
2. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004 3 : 394 400.
3. Kruidenier L, Verspaget HW. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease. Aliment Pharmacol Ther 2002 16 : 1997 2015.
4. Pavlick KP, Laroux FS, Fuseler J et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 2002 33 : 311 22.
5. Pravda J. Radical induction theory of ulcerative colitis. World J Gastroenterol 2005 11 : 2371 84.
6. Levine AD. Apoptosis: implications for inflammatory bowel disease. Inflamm Bowel Dis 2000 6 : 191 205.
7. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 2007 47 : 143 83.
8. Wu HG, Gong X, Yao LQ et al. Mechanisms of acapuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis. World J Gastroenterol 2004 10 : 682 8.
9. Mazzon E, Esposito E, Crisafulli C et al. Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. J Pineal Res 2006 41 : 363 73.
10. Verstege MI, Te Velde AA, Hommes DW. Apoptosis as a therapeutic paradigm in inflammatory bowel diseases. Acta Gastroenterol Belg 2006 69 : 406 12.
11. Karamanolis DG, Kyrlagkitsis I, Konstantinou K et al. The Bcl-2/Bax system and apoptosis in ulcerative colitis. Hepatogastroenterology 2007 54 : 1085 8.
12. Hansen SH. The role of taurine in diabetes and the development of diabetic complications. Diabetes Metab Res Rev 2001 17 : 330 46.
13. Schaffer S, Azuma J, Takahashi K, Mozaffari M. Why is taurine cytoprotective? Adv Exp Med Biol 2003 526 : 307 21.
14. Redmond HP, Wang JH, Bouchier-Hayes D. Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury. Arch Surg 1996 131 : 1280 8.
15. Balkan J, Kanbagli Ö, Hatipoǧlu A et al. Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a high-cholesterol diet. Biosci Biotechnol Biochem 2002 66 : 1755 8.
16. Franconi F, Di Leo MAS, Bennardini F, Ghirlanda G. Is taurine beneficial in reducing risk factors for diabetes mellitus? Neurochem Res 2004 29 : 143 50.
17. Doǧru-Abbasoǧlu S, Kanbagli Ö, Balkan J, Çevikbaş U, Aykaç-Toker G, Uysal M. The protective effect of taurine against thioacetamide hepatotoxicity of rats. Hum Exp Toxicol 2001 20 : 23 7.
18. Çetiner M, Şener G, Şehirli AÖ et al. Taurine protects against methotrexate-induced toxicity and inhibits leucocyte death. Toxicol Appl Pharmacol 2005 209 : 39 50.
19. Oriyanhan W, Yamazaki K, Miwa S, Takaba K, Ikeda T, Komeda M. Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels 2005 20 : 278 85.
20. Casey RG, Gang C, Joyce M, Bouchier-Heyes DJ. Taurine attenuates acute hyperglycaemia-induced endothelial cell apoptosis, leucocyte-endothelial cell interactions and cardiac dysfunction. J Vasc Res 2007 44 : 31 9.
21. Eppler B, Dawson R. Dietary taurine manipulations in aged male Fischer 344 rat tissue: taurine concentration, taurine biosynthesis, and oxidative markers. Biochem Pharmacol 2002 62 : 29 39.
22. Erman F, Balkan J, Çevikbaş U, Koçak-Toker N, Uysal M. Betaine or taurine administration prevents fibrosis and lipid peroxidation induced by rat liver by ethanol plus carbon tetrachloride intoxication. Amino Acids 2004 27 : 199 205.
23. Hagar HH. The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett 2004 151 : 335 43.
24. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989 96 : 795 803.
25. Millar AD, Rampton DS, Chander CL et al. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 1996 39 : 407 15.
26. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982 78 : 206 9.
27. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978 52 : 302 10.
28. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissues with Ellmann's reagent. Anal Biochem 1968 25 : 192 205.
29. Liu ESL, Ye Y-N, Shin VY et al. Cigarette smoke exposure increases ulcerative colitis-associated colonic adenoma formation in mice. Carcinogenesis 2003 24 : 1407 13.
30. Christensen JG, Romach EH, Healy LN et al. Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice. Carcinogenesis 1999 20 : 1583 90.
31. Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic. Anal Biochem 1985 150 : 76 85.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage t4. Nature 1970 227 : 680 5.
33. Neurath M, Fuss I, Strober W. TNBS-colitis. Int Rev Immunol 2000 19 : 51 62.
34. Lih-Brody L, Powell SR, Collier KP et al. Increased oxidative stress and decreased antioxidant defences in mucosa of inflammatory bowel disease. Dig Dis Sci 1996 41 : 2078 86.
35. Tüzün A, Erdil A, Inal V et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 2002 35 : 569 72.
36. Çetinkaya A, Bülbüloǧlu E, Kantarçeken B et al. Effects of 1-carnitine on oxidant/antioxidant status in acetic acid-induced colitis. Dig Dis Sci 2006 51 : 488 94.
37. Deǧer C, Erbil Y, Giriş M et al. The effect of glutamine on pancreatic damage in TNBS-induced colitis. Dig Dis Sci 2006 51 : 1841 6.
38. Hagar HH, El Medany A, El Eter E, Arafa M. Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats. Eur J Pharmacol 2007 554 : 69 77.
39. Giriş M, Erbil Y, Doǧru-Abbasoǧlu S et al. The effect of heme oxygenase-1 induction by glutamine on TNBS-induced colitis. Int J Colorectal Dis 2007 22 : 591 9.
40. Son M, Ko JI, Doh HM et al. Protective effect of taurine on TNBS-induced inflammatory bowel disease in rats. Arch Pharm Res 1998 21 : 531 6.